Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 180

1.

Genome-wide association study revealed novel loci which aggravate asymptomatic hyperuricaemia into gout.

Kawamura Y, Nakaoka H, Nakayama A, Okada Y, Yamamoto K, Higashino T, Sakiyama M, Shimizu T, Ooyama H, Ooyama K, Nagase M, Hidaka Y, Shirahama Y, Hosomichi K, Nishida Y, Shimoshikiryo I, Hishida A, Katsuura-Kamano S, Shimizu S, Kawaguchi M, Uemura H, Ibusuki R, Hara M, Naito M, Takao M, Nakajima M, Iwasawa S, Nakashima H, Ohnaka K, Nakamura T, Stiburkova B, Merriman TR, Nakatochi M, Ichihara S, Yokota M, Takada T, Saitoh T, Kamatani Y, Takahashi A, Arisawa K, Takezaki T, Tanaka K, Wakai K, Kubo M, Hosoya T, Ichida K, Inoue I, Shinomiya N, Matsuo H.

Ann Rheum Dis. 2019 Jul 8. pii: annrheumdis-2019-215521. doi: 10.1136/annrheumdis-2019-215521. [Epub ahead of print]

2.

Bridge of preoperative biliary drainage is a useful management for patients undergoing pancreaticoduodenectomy.

Endo Y, Noda H, Watanabe F, Kakizawa N, Fukui T, Kato T, Ichida K, Aizawa H, Kasahara N, Rikiyama T.

Pancreatology. 2019 Jul;19(5):775-780. doi: 10.1016/j.pan.2019.06.013. Epub 2019 Jun 23.

PMID:
31255445
3.

A lack of postoperative complications after pancreatectomy contributes to the long-term survival of patients with pancreatic cancer.

Kasahara N, Noda H, Kakizawa N, Kato T, Watanabe F, Ichida K, Endo Y, Aizawa H, Rikiyama T.

Pancreatology. 2019 Jul;19(5):686-694. doi: 10.1016/j.pan.2019.06.012. Epub 2019 Jun 22.

PMID:
31253497
4.

High relative levels of satellite alpha transcripts predict increased risk of bilateral breast cancer and multiple primary cancer in patients with breast cancer and lacking BRCA‑related clinical features.

Kakizawa N, Suzuki K, Abe I, Endo Y, Tamaki S, Ishikawa H, Watanabe F, Ichida K, Saito M, Futsuhara K, Konishi F, Rikiyama T.

Oncol Rep. 2019 Aug;42(2):857-865. doi: 10.3892/or.2019.7182. Epub 2019 Jun 3.

PMID:
31173247
5.

A Retrospective Analysis of Preoperative Evaluation and Surgical Resection for Metastatic Tumors of the Pancreas.

Endo Y, Noda H, Watanabe F, Kato T, Kakizawa N, Ichida K, Kasahara N, Rikiyama T.

Indian J Surg Oncol. 2019 Jun;10(2):251-257. doi: 10.1007/s13193-019-00905-w. Epub 2019 Mar 18.

PMID:
31168244
6.

Establishment of novel monoclonal antibodies for identification of type A spermatogonia in teleosts1.

Hayashi M, Ichida K, Sadaie S, Miwa M, Fujihara R, Nagasaka Y, Yoshizaki G.

Biol Reprod. 2019 May 11. pii: ioz080. doi: 10.1093/biolre/ioz080. [Epub ahead of print]

PMID:
31077286
7.

Multiple primary malignancies of six organs in a Japanese male patient: A case report.

Muto Y, Suzuki K, Kato T, Ichida K, Takayama Y, Fukui T, Kakizawa N, Watanabe F, Kaneda Y, Noda H, Rikiyama T.

Mol Clin Oncol. 2019 May;10(5):511-515. doi: 10.3892/mco.2019.1819. Epub 2019 Mar 4.

8.

Characterization and expression of a vasa homolog in the gonads and primordial germ cells of the striped catfish (Pangasianodon hypophthalmus).

Duangkaew R, Jangprai A, Ichida K, Yoshizaki G, Boonanuntanasarn S.

Theriogenology. 2019 Jun;131:61-71. doi: 10.1016/j.theriogenology.2019.01.022. Epub 2019 Mar 15.

PMID:
30947076
9.

Specific visualization of live type A spermatogonia of Pacific bluefin tuna using fluorescent dye-conjugated antibodies†.

Ichida K, Kawamura W, Miwa M, Iwasaki Y, Kubokawa T, Hayashi M, Yazawa R, Yoshizaki G.

Biol Reprod. 2019 Jun 1;100(6):1637-1647. doi: 10.1093/biolre/ioz047.

PMID:
30934056
10.

Clinical practice guideline for renal hypouricemia (1st edition).

Nakayama A, Matsuo H, Ohtahara A, Ogino K, Hakoda M, Hamada T, Hosoyamada M, Yamaguchi S, Hisatome I, Ichida K, Shinomiya N.

Hum Cell. 2019 Apr;32(2):83-87. doi: 10.1007/s13577-019-00239-3. Epub 2019 Feb 19. Review.

11.

A letter of reply to the commentary by Dr. Stamp et al.

Ichida K.

Drug Metab Pharmacokinet. 2019 Feb;34(1):111-112. doi: 10.1016/j.dmpk.2018.12.001. Epub 2018 Dec 15. No abstract available.

PMID:
30709683
12.

The Persistent Generalized Muscle Contraction in Siblings with Molybdenum Cofactor Deficiency Type A.

Yoshimura A, Kibe T, Hasegawa H, Ichida K, Koshimizu E, Miyatake S, Matsumoto N, Yokochi K.

Neuropediatrics. 2019 Apr;50(2):126-129. doi: 10.1055/s-0039-1677869. Epub 2019 Jan 29.

PMID:
30695801
13.

Urate Transport via Paracellular Route across Epithelial Cells.

Kimura T, Tsukada A, Fukutomi T, Ichida K, Ohtsuki S, Sakurai H.

Biol Pharm Bull. 2019;42(1):43-49. doi: 10.1248/bpb.b18-00505.

14.

Renal stone and chronic kidney failure associated with hypouricemia: Answers.

Aksoy GK, Koyun M, Ichida K, Comak E, Akman S.

Pediatr Nephrol. 2019 Jul;34(7):1225-1227. doi: 10.1007/s00467-018-4170-5. Epub 2018 Dec 19. No abstract available.

PMID:
30569312
15.

Renal stone and chronic kidney failure associated with hypouricemia: Questions.

Aksoy GK, Koyun M, Ichida K, Comak E, Akman S.

Pediatr Nephrol. 2019 Jul;34(7):1223-1224. doi: 10.1007/s00467-018-4163-4. Epub 2018 Dec 19. No abstract available.

PMID:
30569310
16.

Pharmacokinetics and toxicokinetics of d-serine in rats.

Hasegawa H, Masuda N, Natori H, Shinohara Y, Ichida K.

J Pharm Biomed Anal. 2019 Jan 5;162:264-271. doi: 10.1016/j.jpba.2018.09.026. Epub 2018 Sep 14.

PMID:
30268994
17.

Diet-induced hyperhomocysteinemia impairs vasodilation in 5/6-nephrectomized rats.

Li L, Hasegawa H, Inaba N, Yoshioka W, Chang D, Liu J, Ichida K.

Amino Acids. 2018 Oct;50(10):1485-1494. doi: 10.1007/s00726-018-2626-3. Epub 2018 Jul 30.

PMID:
30062489
18.

Identification of ABCG2 as an Exporter of Uremic Toxin Indoxyl Sulfate in Mice and as a Crucial Factor Influencing CKD Progression.

Takada T, Yamamoto T, Matsuo H, Tan JK, Ooyama K, Sakiyama M, Miyata H, Yamanashi Y, Toyoda Y, Higashino T, Nakayama A, Nakashima A, Shinomiya N, Ichida K, Ooyama H, Fujimori S, Suzuki H.

Sci Rep. 2018 Jul 24;8(1):11147. doi: 10.1038/s41598-018-29208-w.

19.

Monitoring circulating tumor DNA revealed dynamic changes in KRAS status in patients with metastatic colorectal cancer.

Takayama Y, Suzuki K, Muto Y, Ichida K, Fukui T, Kakizawa N, Ishikawa H, Watanabe F, Hasegawa F, Saito M, Tsujinaka S, Futsuhara K, Miyakura Y, Noda H, Konishi F, Rikiyama T.

Oncotarget. 2018 May 11;9(36):24398-24413. doi: 10.18632/oncotarget.25309. eCollection 2018 May 11.

20.

Overexpression of satellite alpha transcripts leads to chromosomal instability via segregation errors at specific chromosomes.

Ichida K, Suzuki K, Fukui T, Takayama Y, Kakizawa N, Watanabe F, Ishikawa H, Muto Y, Kato T, Saito M, Futsuhara K, Miyakura Y, Noda H, Ohmori T, Konishi F, Rikiyama T.

Int J Oncol. 2018 Mar 16. doi: 10.3892/ijo.2018.4321. [Epub ahead of print]

PMID:
29568894
21.

URAT1 and GLUT9 mutations in Spanish patients with renal hypouricemia.

Claverie-Martin F, Trujillo-Suarez J, Gonzalez-Acosta H, Aparicio C, Justa Roldan ML, Stiburkova B, Ichida K, Martín-Gomez MA, Herrero Goñi M, Carrasco Hidalgo-Barquero M, Iñigo V, Enriquez R, Cordoba-Lanus E, Garcia-Nieto VM; RenalTube Group.

Clin Chim Acta. 2018 Jun;481:83-89. doi: 10.1016/j.cca.2018.02.030. Epub 2018 Feb 24.

PMID:
29486147
22.

Effect of triclosan-coated sutures on the incidence of surgical site infection after abdominal wall closure in gastroenterological surgery: a double-blind, randomized controlled trial in a single center.

Ichida K, Noda H, Kikugawa R, Hasegawa F, Obitsu T, Ishioka D, Fukuda R, Yoshizawa A, Tsujinaka S, Rikiyama T.

Surgery. 2018 Mar 10. pii: S0039-6060(17)30893-0. doi: 10.1016/j.surg.2017.12.020. [Epub ahead of print]

PMID:
29402448
23.

Investigation of the transport of xanthine dehydrogenase inhibitors by the urate transporter ABCG2.

Nakamura M, Fujita K, Toyoda Y, Takada T, Hasegawa H, Ichida K.

Drug Metab Pharmacokinet. 2018 Feb;33(1):77-81. doi: 10.1016/j.dmpk.2017.11.002. Epub 2017 Nov 22.

PMID:
29342419
24.

Eagle's syndrome.

Tomoda Y, Ichida K, Kagawa S, Kurata S, Tanaka K.

QJM. 2018 Jun 1;111(6):417. doi: 10.1093/qjmed/hcx259. No abstract available.

PMID:
29301055
25.

ABCG2 as a therapeutic target candidate for gout.

Fujita K, Ichida K.

Expert Opin Ther Targets. 2018 Feb;22(2):123-129. doi: 10.1080/14728222.2018.1420167. Epub 2017 Dec 28. Review.

PMID:
29264928
26.

Multiple common and rare variants of ABCG2 cause gout.

Higashino T, Takada T, Nakaoka H, Toyoda Y, Stiburkova B, Miyata H, Ikebuchi Y, Nakashima H, Shimizu S, Kawaguchi M, Sakiyama M, Nakayama A, Akashi A, Tanahashi Y, Kawamura Y, Nakamura T, Wakai K, Okada R, Yamamoto K, Hosomichi K, Hosoya T, Ichida K, Ooyama H, Suzuki H, Inoue I, Merriman TR, Shinomiya N, Matsuo H.

RMD Open. 2017 Aug 29;3(2):e000464. doi: 10.1136/rmdopen-2017-000464. eCollection 2017.

27.

En bloc pancreaticoduodenectomy and right hemicolectomy for locally advanced right-sided colon cancer.

Kaneda Y, Noda H, Endo Y, Kakizawa N, Ichida K, Watanabe F, Kato T, Miyakura Y, Suzuki K, Rikiyama T.

World J Gastrointest Oncol. 2017 Sep 15;9(9):372-378. doi: 10.4251/wjgo.v9.i9.372.

28.

A High Abdominal Aortic Calcification Score on CT is a Risk Factor for Postoperative Pancreatic Fistula in Elderly Patients Undergoing Pancreaticoduodenectomy.

Kakizawa N, Noda H, Watanabe F, Ichida K, Suzuki K, Rikiyama T.

World J Surg. 2018 Apr;42(4):1129-1137. doi: 10.1007/s00268-017-4240-z.

PMID:
28929356
29.

Morphological response contributes to patient selection for rescue liver resection in chemotherapy patients with initially un-resectable colorectal liver metastasis.

Suzuki K, Muto Y, Ichida K, Fukui T, Takayama Y, Kakizawa N, Kato T, Hasegawa F, Watanabe F, Kaneda Y, Kikukawa R, Saito M, Tsujinaka S, Futsuhara K, Takata O, Noda H, Miyakura Y, Kiyozaki H, Konishi F, Rikiyama T.

Oncol Lett. 2017 Aug;14(2):1491-1499. doi: 10.3892/ol.2017.6338. Epub 2017 Jun 7.

30.

Flow-cytometric enrichment of Pacific bluefin tuna type A spermatogonia based on light-scattering properties.

Ichida K, Kise K, Morita T, Yazawa R, Takeuchi Y, Yoshizaki G.

Theriogenology. 2017 Oct 1;101:91-98. doi: 10.1016/j.theriogenology.2017.06.022. Epub 2017 Jun 22. Review.

PMID:
28708521
31.

Sequential administration of XELOX and XELIRI is effective, feasible and well tolerated by patients with metastatic colorectal cancer.

Fukui T, Suzuki K, Ichida K, Takayama Y, Kakizawa N, Muto Y, Hasegawa F, Watanabe F, Kikugawa R, Saito M, Tsujinaka S, Miyakura Y, Rikiyama T.

Oncol Lett. 2017 Jun;13(6):4947-4952. doi: 10.3892/ol.2017.6100. Epub 2017 Apr 26.

32.

Independent effects of ADH1B and ALDH2 common dysfunctional variants on gout risk.

Sakiyama M, Matsuo H, Akashi A, Shimizu S, Higashino T, Kawaguchi M, Nakayama A, Naito M, Kawai S, Nakashima H, Sakurai Y, Ichida K, Shimizu T, Ooyama H, Shinomiya N.

Sci Rep. 2017 May 31;7(1):2500. doi: 10.1038/s41598-017-02528-z.

33.

A case of xanthinuria type I with a novel mutation in xanthine dehydrogenase.

Iguchi A, Sato T, Yamazaki M, Tasaki K, Suzuki Y, Iino N, Hasegawa H, Ichida K, Narita I.

CEN Case Rep. 2016 Nov;5(2):158-162. doi: 10.1007/s13730-016-0216-3. Epub 2016 Mar 3.

34.

Multiple Gouty Tophi with Bone Erosion and Destruction: A Report of an Early-onset Case in an Obese Patient.

D Hayashi R, Yamaoka M, Nishizawa H, Fukuda S, Fujishima Y, Kimura T, Kozawa J, Kita S, Matsuoka TA, Otsuki M, Imagawa A, Ichida K, Taniguchi A, Maeda N, Funahashi T, Shimomura I.

Intern Med. 2017;56(9):1071-1077. doi: 10.2169/internalmedicine.56.7923. Epub 2017 May 1.

35.

Clinical and molecular assessment of regorafenib monotherapy.

Kakizawa N, Suzuki K, Fukui T, Takayama Y, Ichida K, Muto Y, Hasegawa F, Watanabe F, Kikugawa R, Tsujinaka S, Futsuhara K, Miyakura Y, Noda H, Rikiyama T.

Oncol Rep. 2017 Apr;37(4):2506-2512. doi: 10.3892/or.2017.5456. Epub 2017 Feb 15.

PMID:
28259999
36.

Identification of Febuxostat as a New Strong ABCG2 Inhibitor: Potential Applications and Risks in Clinical Situations.

Miyata H, Takada T, Toyoda Y, Matsuo H, Ichida K, Suzuki H.

Front Pharmacol. 2016 Dec 27;7:518. doi: 10.3389/fphar.2016.00518. eCollection 2016.

37.

Expression of a human NPT1/SLC17A1 missense variant which increases urate export.

Sakiyama M, Matsuo H, Nagamori S, Ling W, Kawamura Y, Nakayama A, Higashino T, Chiba T, Ichida K, Kanai Y, Shinomiya N.

Nucleosides Nucleotides Nucleic Acids. 2016 Dec;35(10-12):536-542.

PMID:
27906618
38.

GWAS of clinically defined gout and subtypes identifies multiple susceptibility loci that include urate transporter genes.

Nakayama A, Nakaoka H, Yamamoto K, Sakiyama M, Shaukat A, Toyoda Y, Okada Y, Kamatani Y, Nakamura T, Takada T, Inoue K, Yasujima T, Yuasa H, Shirahama Y, Nakashima H, Shimizu S, Higashino T, Kawamura Y, Ogata H, Kawaguchi M, Ohkawa Y, Danjoh I, Tokumasu A, Ooyama K, Ito T, Kondo T, Wakai K, Stiburkova B, Pavelka K, Stamp LK, Dalbeth N; Eurogout Consortium, Sakurai Y, Suzuki H, Hosoyamada M, Fujimori S, Yokoo T, Hosoya T, Inoue I, Takahashi A, Kubo M, Ooyama H, Shimizu T, Ichida K, Shinomiya N, Merriman TR, Matsuo H; Eurogout Consortium.

Ann Rheum Dis. 2017 May;76(5):869-877. doi: 10.1136/annrheumdis-2016-209632. Epub 2016 Nov 29.

39.

A novel compound heterozygous mutation in the SLC22A12 (URAT1) gene in a Japanese patient associated with renal hypouricemia.

Fujita K, Ichida K.

Clin Chim Acta. 2016 Dec 1;463:119-121. doi: 10.1016/j.cca.2016.10.025. Epub 2016 Oct 22.

PMID:
27780716
40.

Meta-analysis confirms an association between gout and a common variant of LRRC16A locus.

Ogata H, Matsuo H, Sakiyama M, Higashino T, Kawaguchi M, Nakayama A, Naito M, Ooyama H, Ichida K, Shinomiya N.

Mod Rheumatol. 2017 May;27(3):553-555. doi: 10.1080/14397595.2016.1218413. Epub 2016 Sep 1. No abstract available.

PMID:
27585540
41.

Hyperuricemia in acute gastroenteritis is caused by decreased urate excretion via ABCG2.

Matsuo H, Tsunoda T, Ooyama K, Sakiyama M, Sogo T, Takada T, Nakashima A, Nakayama A, Kawaguchi M, Higashino T, Wakai K, Ooyama H, Hokari R, Suzuki H, Ichida K, Inui A, Fujimori S, Shinomiya N.

Sci Rep. 2016 Aug 30;6:31003. doi: 10.1038/srep31003.

42.

Characterization of a vasa homolog in the brown-marbled grouper (Epinephelus fuscoguttatus) and its expression in gonad and germ cells during larval development.

Boonanuntanasarn S, Bunlipatanon P, Ichida K, Yoohat K, Mengyu O, Detsathit S, Yazawa R, Yoshizaki G.

Fish Physiol Biochem. 2016 Dec;42(6):1621-1636. Epub 2016 Jul 12.

PMID:
27406385
43.

Heterogeneous expression of zinc-finger E-box-binding homeobox 1 plays a pivotal role in metastasis via regulation of miR-200c in epithelial-mesenchymal transition.

Muto Y, Suzuki K, Kato T, Tsujinaka S, Ichida K, Takayama Y, Fukui T, Kakizawa N, Watanabe F, Saito M, Futsuhara K, Noda H, Miyakura Y, Konishi F, Rikiyama T.

Int J Oncol. 2016 Sep;49(3):1057-67. doi: 10.3892/ijo.2016.3583. Epub 2016 Jun 17.

PMID:
27315529
44.

Diagnosis of desmoplastic small-round-cell tumor by cytogenetic analysis: a case report.

Wakahashi S, Sudo T, Ichida K, Sugita S, Hasegawa T, Nagao S, Yamaguchi S, Sakuma T, Yamada H.

Clin Case Rep. 2016 Apr 15;4(5):520-3. doi: 10.1002/ccr3.558. eCollection 2016 May.

45.

Malignant, but not benign, intraductal papillary mucinous neoplasm preferentially associates with prior extrapancreatic malignancies.

Kato T, Alonso S, Noda H, Miyakura Y, Tsujinaka S, Saito M, Muto Y, Fukui T, Ichida K, Takayama Y, Watanabe F, Kakizawa N, Perucho M, Rikiyama T.

Oncol Rep. 2016 Jun;35(6):3236-40. doi: 10.3892/or.2016.4755. Epub 2016 Apr 19.

PMID:
27108615
46.

A preoperative low cancer antigen 125 level (≤25.8 mg/dl) is a useful criterion to determine the optimal timing of interval debulking surgery following neoadjuvant chemotherapy in epithelial ovarian cancer.

Morimoto A, Nagao S, Kogiku A, Yamamoto K, Miwa M, Wakahashi S, Ichida K, Sudo T, Yamaguchi S, Fujiwara K.

Jpn J Clin Oncol. 2016 Jun;46(6):517-21. doi: 10.1093/jjco/hyw029. Epub 2016 Mar 13.

PMID:
26977055
47.

Rare case of nephrocalcinosis in the distal tubules caused by hereditary renal hypouricaemia 3 months after kidney transplantation.

Okabayashi Y, Yamamoto I, Komatsuzaki Y, Niikura T, Yamakawa T, Katsumata H, Kawabe M, Katsuma A, Nakada Y, Kobayashi A, Koike Y, Miki J, Yamada H, Tanno Y, Ohkido I, Tsuboi N, Ichida K, Yamamoto H, Yokoo T.

Nephrology (Carlton). 2016 Jul;21 Suppl 1:67-71. doi: 10.1111/nep.12774. Review.

PMID:
26971588
48.

The effects of URAT1/SLC22A12 nonfunctional variants, R90H and W258X, on serum uric acid levels and gout/hyperuricemia progression.

Sakiyama M, Matsuo H, Shimizu S, Nakashima H, Nakamura T, Nakayama A, Higashino T, Naito M, Suma S, Hishida A, Satoh T, Sakurai Y, Takada T, Ichida K, Ooyama H, Shimizu T, Shinomiya N.

Sci Rep. 2016 Jan 29;6:20148. doi: 10.1038/srep20148.

49.

Functional analysis of novel allelic variants in URAT1 and GLUT9 causing renal hypouricemia type 1 and 2.

Mancikova A, Krylov V, Hurba O, Sebesta I, Nakamura M, Ichida K, Stiburkova B.

Clin Exp Nephrol. 2016 Aug;20(4):578-584. doi: 10.1007/s10157-015-1186-z. Epub 2015 Oct 24.

PMID:
26500098
50.

Circularly Polarized Luminescence of Chiral Pt(pppb)Cl (pppbH=1-pyridyl-3-(4,5-pinenopyridyl)benzene) Aggregate in the Excited State.

Tanaka S, Sato K, Ichida K, Abe T, Tsubomura T, Suzuki T, Shinozaki K.

Chem Asian J. 2016 Jan;11(2):265-73. doi: 10.1002/asia.201500985. Epub 2015 Oct 28.

PMID:
26450766

Supplemental Content

Loading ...
Support Center